January 29 (SeeNews) - Bosnian drug maker Bosnalijek [SAJ:BSNLR] said its new 50 million marka ($28 million/26 million euro) plant for liquid and semisolid pharmaceutical forms has received a Good Manufacturing Practice (GMP) certificate that allows it to export its output to the European Union.